Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AbbVie
Company Monitoring Page for AbbVie
latest headlines for company on cafepharma
Revance wants you to 'Break Up With Botox' as it goes to war with AbbVie in new anti-wrinkle market battle
Fierce Pharma
Mon, 07/3/23 - 10:44 am
Tags:
Revance Therapeutics
,
Daxxify
,
pharma marketing
,
AbbVie
,
Botox
Alvotech to raise cash after third FDA rejection for Humira biosimilar
BioPharma Dive
Fri, 06/30/23 - 11:39 am
Tags:
Alvotech
,
Teva Pharmaceutical
,
AbbVie
,
Humira
,
biosimilars
,
FDA
AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug
BioSpace
Thu, 06/29/23 - 11:15 pm
Tags:
AbbVie
,
Genmab
,
Roche
,
follicular lymphoma
,
bispecific antibodies
,
epcoritamab
,
Lunsumio
Genmab and AbbVie plan next steps for Epkinly in follicular lymphoma
Clinical Trials Arena
Wed, 06/28/23 - 10:27 am
Tags:
AbbVie
,
Genmab
,
Epkinly
,
clinical trials
,
relapsed or refractory follicular lymphoma
What Will AbbVie Buy Next?
Motley Fool
Wed, 06/28/23 - 10:01 am
Tags:
AbbVie
,
M&A
,
Blueprint Medicines
,
Krystal Biotech
AbbVie's Imbruvica-Brukinsa patent suit may have merit, and BeiGene will likely settle: expert
Fierce Pharma
Tue, 06/27/23 - 10:21 pm
Tags:
AbbVie
,
patents
,
BeiGene
,
legal
,
Btk inhibitors
AbbVie's Skyrizi posts ulcerative colitis win in maintenance study, teeing up FDA nod
Fierce Pharma
Fri, 06/16/23 - 10:12 am
Tags:
AbbVie
,
ulcerative colitis
,
Skyrizi
,
FDA
AbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up
Fierce Pharma
Fri, 06/16/23 - 09:44 am
Tags:
AbbVie
,
Pharmacyclics
,
BeiGene
,
Brukinsa
,
patents
,
Imbruvica
,
blood cancer
Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends
Fierce Pharma
Thu, 06/15/23 - 06:55 pm
Tags:
AbbVie
,
Humira
,
biosimilars
,
Mark Cuban Cost Plus Drugs
,
Coherus Biosciences
Pharma Companies, Pharmacies Agree to Pay $19B in Opioid Settlement
BioSpace
Mon, 06/12/23 - 10:15 am
Tags:
opioids
,
opioid crisis
,
legal
,
pharmacies
,
McKesson
,
AmerisourceBergen
,
Cardinal Health
,
Teva Pharmaceutical
,
AbbVie
,
JNJ
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
Tags:
AstraZeneca
,
IBD
,
AbbVie
,
JNJ
,
brazikumab
,
Skyrizi
,
Stelara
Mark Cuban online pharmacy to offer AbbVie Humira biosimilar
Seeking Alpha
Thu, 06/1/23 - 11:29 am
Tags:
AbbVie
,
Mark Cuban
,
Humira
,
biosimilar
,
Coherus Biosciences
,
Mark Cuban Cost Plus Drugs
,
Yusimry
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
Fierce Pharma
Wed, 05/31/23 - 11:06 am
Tags:
AbbVie
,
Rinvoq
,
Humira
,
systemic lupus erythematosus
,
lupus
,
clinical trials
AbbVie, Genmab's lymphoma drug Epkinly snags FDA approval in heated blood cancer race
Fierce Pharma
Sun, 05/21/23 - 07:46 pm
Tags:
AbbVie
,
Genmab
,
FDA
,
anti-CD20
,
epcoritamab
,
diffuse large B-cell lymphoma
,
Epkinly
AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease
Fierce Pharma
Thu, 05/18/23 - 08:36 pm
Tags:
AbbVie
,
FDA
,
Rinvoq
,
Crohn's Disease
,
Humira
Allergan's new skin-smoothing product gets FDA nod—with novel delivery mechanism
Fierce Pharma
Wed, 05/17/23 - 10:40 pm
Tags:
AbbVie
,
FDA
,
Skinvive
,
Juvederm
,
aesthetics
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA
,
drug approvals
,
accelerated approvals
,
AbbVie
,
AstraZeneca
,
Bayer
,
Bristol Myers Squibb
,
JNJ
,
Merck
,
Merck KGaA
,
Novartis
,
Pfizer
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches
,
AbbVie
,
Almirall
,
Apellis Pharmaceuticals
,
Astellas
,
AstraZeneca
,
Biogen
,
CRISPR Therapeutics
,
Daiichi Sankyo
,
Eli Lilly
,
Genmab
,
GSK
,
Iveric Bio
,
Pfizer
,
Roche
,
SAGE Therapeutics
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Vertex Pharmaceuticals
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie
,
Amgen
,
AstraZeneca
,
Bristol Myers Squibb
,
Daiichi Sankyo
,
Eli Lilly
,
Gilead Sciences
,
Horizon Therapeutics
,
Merck
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
2 Things About AbbVie That Investors Are Ignoring
Motley Fool
Wed, 05/3/23 - 10:34 pm
Tags:
AbbVie
,
immunology
,
aesthetics
,
Neuroscience
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.